top of page

FLYER

PROTAC-Mediated CDK2 Degradation in Oncology: A Case Study with Revvity and Beantown Biotech

Accelerating targeted protein degradation research with AlphaLISA SureFire® Ultra and HTRF no-wash immunoassays.

CDK2 Protein Structure.png

United in Science: A Beantown Biotech and Revvity Inc. Collaboration

Explore how AlphaLISA SureFire® Ultra and HTRF can be used to investigate PROTAC (proteolysis-targeting chimera)-mediated protein degradation. Learn how these assay technologies can support sensitive, quantitative analysis of target protein degradation in this case study of CPS2-mediated CDK2 degradation.

PROTAC Schematic.png
CDK2 protein structure, RSBC PDB: pdb_00001hck

REPRESENTATIVE DATA

Dose-response curves (percent response) illustrating the half-maximal degradation concentration (DC50) for CPS2-induced CDK2 degradation, measured using AlphaLISA SureFire® Ultra and HTRF assay technologies.

Let’s Discuss Your Project

Contact us to discuss your research needs and learn how Beantown Biotech can support your drug discovery goals.

Beantown-Logos-Final_v copy.png

700 Technology Park Dr,

Suite 204,
Billerica, MA 01821

Follow Us On:

Email: info@beantownbiotech.com

Tel: 1-508-975-4753

Privacy Policy

  • LinkedIn
Prendio Preferred Supplier Logo (1)_edit

© 2023 by Beantown Biotech

bottom of page